Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro Barrera

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Evidence-Based Nursing|July 27, 2023
Trust and confidence of clinical staff and patients is crucial for the successful introduction of artificial intelligence (AI) in mental healthcareAlvaro Barrera
Schizophrenia Bulletin|January 17, 2025
Formal Thought Disorder in Schizophrenia: A Problematic HistoryAlvaro Barrera
Acta Pharmaceutica Sinica. B|July 19, 2024
Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's diseaseAlvaro Barrera-Ocampo
Revista Medica De Chile|October 6, 2010
[Bipolar depression and unipolar depression: differential diagnosis in clinical practice]Fanny Leyton, Alvaro Barrera
Journal of Clinical Psychopharmacology|November 6, 2023
Paroxysmal Perceptual Alterations in Response to FlupentixolJonathan Phillips, Alvaro Barrera
The Journal of ECT|February 27, 2024
Report of an Observation Regarding Administering Electroconvulsive Therapy at NightMartin Cordero, Alvaro Barrera
Schizophrenia Bulletin|April 8, 2015
Schizophrenia, Subjectivity, and MindreadingMatthew M Nour, Alvaro Barrera
BMJ Case Reports|June 23, 2019
Clozapine-induced pericarditis: an ethical dilemmaHarleen Kaur Johal, Alvaro Barrera
Colombia Medica (Cali, Colombia)|March 16, 2017
Amyloid-beta immunotherapy: the hope for Alzheimer disease?Alvaro Barrera-Ocampo, Francisco Lopera
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 6, 2013
Contribution of postsynaptic molecules to AMPA receptor nanodomain organizationAlvaro Barrera-Ocampo, Thomas E Chater
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Evidence-Based Nursing|July 27, 2023
Trust and confidence of clinical staff and patients is crucial for the successful introduction of artificial intelligence (AI) in mental healthcareAlvaro Barrera
Schizophrenia Bulletin|January 17, 2025
Formal Thought Disorder in Schizophrenia: A Problematic HistoryAlvaro Barrera
Acta Pharmaceutica Sinica. B|July 19, 2024
Monoclonal antibodies and aptamers: The future therapeutics for Alzheimer's diseaseAlvaro Barrera-Ocampo
Revista Medica De Chile|October 6, 2010
[Bipolar depression and unipolar depression: differential diagnosis in clinical practice]Fanny Leyton, Alvaro Barrera
Journal of Clinical Psychopharmacology|November 6, 2023
Paroxysmal Perceptual Alterations in Response to FlupentixolJonathan Phillips, Alvaro Barrera
The Journal of ECT|February 27, 2024
Report of an Observation Regarding Administering Electroconvulsive Therapy at NightMartin Cordero, Alvaro Barrera
Schizophrenia Bulletin|April 8, 2015
Schizophrenia, Subjectivity, and MindreadingMatthew M Nour, Alvaro Barrera
BMJ Case Reports|June 23, 2019
Clozapine-induced pericarditis: an ethical dilemmaHarleen Kaur Johal, Alvaro Barrera
Colombia Medica (Cali, Colombia)|March 16, 2017
Amyloid-beta immunotherapy: the hope for Alzheimer disease?Alvaro Barrera-Ocampo, Francisco Lopera
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 6, 2013
Contribution of postsynaptic molecules to AMPA receptor nanodomain organizationAlvaro Barrera-Ocampo, Thomas E Chater
Pageof 5